halothane has been researched along with Heart Failure in 21 studies
Heart Failure: A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
| Excerpt | Relevance | Reference |
|---|---|---|
| " We investigated the effects of different concentrations of sevoflurane, desflurane and halothane in dogs with pacing induced chronic heart failure." | 7.72 | Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure. ( Heiderhoff, M; Hoff, J; Müllenheim, J; Obal, D; Preckel, B; Schlack, W; Thämer, V, 2004) |
| "Halothane was administered at an end-tidal concentration of 1% to 10 patients with stable ischaemic heart disease and clinical and haemodymanic signs of moderate heart failure." | 7.66 | Effects of halothane on coronary haemodynamics and myocardial metabolism in patients with ischaemic heart disease and heart failure. ( Bålfors, E; Gustavsson, B; Häggmark, S; Nath, S; Reiz, S; Rydvall, A; Truedsson, H, 1982) |
| " We investigated the effects of different concentrations of sevoflurane, desflurane and halothane in dogs with pacing induced chronic heart failure." | 3.72 | Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure. ( Heiderhoff, M; Hoff, J; Müllenheim, J; Obal, D; Preckel, B; Schlack, W; Thämer, V, 2004) |
| "Halothane was administered at an end-tidal concentration of 1% to 10 patients with stable ischaemic heart disease and clinical and haemodymanic signs of moderate heart failure." | 3.66 | Effects of halothane on coronary haemodynamics and myocardial metabolism in patients with ischaemic heart disease and heart failure. ( Bålfors, E; Gustavsson, B; Häggmark, S; Nath, S; Reiz, S; Rydvall, A; Truedsson, H, 1982) |
| "Anesthetic indices for methoxyflurane, enflurane, and isoflurane in oxygen and halothane in nitrous oxide and oxygen (50:50), were determined in rats using measurements of heart and brain concentrations of the volatile agents at the endpoints of anesthesia, respiratory arrest and cardiac failure." | 3.66 | Anesthetic indices--further data. ( Hetrick, WD; Lake, CL; Siker, ES; Wolfson, B, 1978) |
| "Vidarabine was intravenously administrated in three escalating doses of 1, 10, 100 mg/kg over 10 min with a pause between the doses (n = 4)." | 1.43 | Antiviral drug vidarabine possessing cardiac type 5 adenylyl cyclase inhibitory property did not affect cardiohemodynamic or electrophysiological variables in the halothane-anesthetized dogs. ( Ando, K; Cao, X; Izumi-Nakaseko, H; Nakamura, Y; Nakazato, Y; Ohara, H; Sugiyama, A; Wada, T, 2016) |
| "The development of congestive heart failure (CHF) was associated with decreases in mean arterial pressure and cardiac output (CO) of 14% and 16%, respectively, (P less than 0." | 1.28 | Cardiovascular effects of volatile anesthesia in rabbits: influence of chronic heart failure and enalaprilat treatment. ( Blake, DW; Langton, D; McGrath, BP; Trigg, L; Way, D, 1991) |
| "In contrast, cardiac failure caused by volatile anesthetics proved to be resistant to this therapy." | 1.25 | Reversible and irreversible forms of contractile failure caused by disturbances by general anesthetics in myocardial ATP utilization. ( Höring, HJ, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (71.43) | 18.7374 |
| 1990's | 2 (9.52) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 1 (4.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wada, T | 1 |
| Nakamura, Y | 1 |
| Cao, X | 1 |
| Ohara, H | 1 |
| Izumi-Nakaseko, H | 1 |
| Ando, K | 1 |
| Nakazato, Y | 1 |
| Sugiyama, A | 1 |
| Cabrera Fischer, EI | 2 |
| Bia, D | 1 |
| Zócalo, Y | 1 |
| Armentano, RL | 1 |
| SMITH, RM | 1 |
| Preckel, B | 1 |
| Müllenheim, J | 1 |
| Hoff, J | 1 |
| Obal, D | 1 |
| Heiderhoff, M | 1 |
| Thämer, V | 1 |
| Schlack, W | 1 |
| Barbry, T | 1 |
| Le Guen, M | 1 |
| De Castro, V | 1 |
| Coriat, P | 1 |
| Riou, B | 1 |
| Vivien, B | 1 |
| Reiz, S | 1 |
| Bålfors, E | 1 |
| Gustavsson, B | 1 |
| Häggmark, S | 1 |
| Nath, S | 1 |
| Rydvall, A | 1 |
| Truedsson, H | 1 |
| Bylsma, F | 1 |
| Walmsley, JB | 1 |
| Wolfson, B | 1 |
| Hetrick, WD | 1 |
| Lake, CL | 1 |
| Siker, ES | 1 |
| Höring, HJ | 1 |
| Blake, DW | 1 |
| Way, D | 1 |
| Trigg, L | 1 |
| Langton, D | 1 |
| McGrath, BP | 1 |
| Chachques, JC | 1 |
| Garcia, A | 1 |
| Pichel, RH | 1 |
| Morales, MC | 1 |
| Carpentier, A | 1 |
| Nechaĭ, AI | 1 |
| Shanin, SS | 1 |
| Gubin, VV | 1 |
| Grady, RF | 1 |
| Hamacher, J | 2 |
| Janssen, I | 1 |
| Shimosato, S | 2 |
| Yasuda, I | 1 |
| Kemmotsu, O | 2 |
| Shanks, C | 1 |
| Gamble, C | 1 |
| Gorodinskaia, VIa | 1 |
| Kilman, JW | 1 |
| Williams, TE | 1 |
| Kakos, GS | 1 |
| Craenen, J | 1 |
| Hosier, DM | 1 |
| Hashimoto, Y | 1 |
| Kaplan, JA | 1 |
| Bitner, RL | 1 |
| Dripps, RD | 1 |
| Brichard, G | 1 |
| Zimmermann, PE | 1 |
| Adenauer, F | 1 |
1 review available for halothane and Heart Failure
| Article | Year |
|---|---|
[Combined effect of beta-adrenoblockaders with other pharmacologic agents (review of the literature)].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia, Inhalation; Angina Pectoris; | 1971 |
20 other studies available for halothane and Heart Failure
| Article | Year |
|---|---|
Antiviral drug vidarabine possessing cardiac type 5 adenylyl cyclase inhibitory property did not affect cardiohemodynamic or electrophysiological variables in the halothane-anesthetized dogs.
Topics: Adenylyl Cyclase Inhibitors; Anesthesia, Inhalation; Animals; Antiviral Agents; Atrial Fibrillation; | 2016 |
Smooth muscle-dependent changes in aortic wall dynamics during intra-aortic counterpulsation in an animal model of acute heart failure.
Topics: Acute Disease; Animals; Aorta; Biomechanical Phenomena; Blood Pressure; Cardiac Output; Disease Mode | 2009 |
ANESTHESIA DURING HYPERBARIC OXYGENATION.
Topics: Anesthesia; Anesthesia, Inhalation; Cardiac Surgical Procedures; Child; Cyanosis; Halothane; Heart D | 1965 |
Haemodynamic changes during halothane, sevoflurane and desflurane anaesthesia in dogs before and after the induction of severe heart failure.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Desflurane; Dogs; Dose-Response Relationsh | 2004 |
Minimum alveolar concentration of halogenated volatile anaesthetics in left ventricular hypertrophy and congestive heart failure in rats.
Topics: Anesthetics, Inhalation; Animals; Disease Progression; Dose-Response Relationship, Drug; Halothane; | 2007 |
Effects of halothane on coronary haemodynamics and myocardial metabolism in patients with ischaemic heart disease and heart failure.
Topics: Aged; Coronary Disease; Female; Halothane; Heart; Heart Failure; Hemodynamics; Humans; Hypoxanthines | 1982 |
Metastatic myocardial calcification.
Topics: Bradycardia; Calcinosis; Cardiomyopathies; Child; Female; Halothane; Heart Failure; Humans; Kidney F | 1981 |
Anesthetic indices--further data.
Topics: Anesthesia, Inhalation; Animals; Brain; Enflurane; Halothane; Heart Failure; Isoflurane; Methoxyflur | 1978 |
Reversible and irreversible forms of contractile failure caused by disturbances by general anesthetics in myocardial ATP utilization.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Anesthetics; Animals; Calcium; Chloroform; Guinea Pig | 1975 |
Cardiovascular effects of volatile anesthesia in rabbits: influence of chronic heart failure and enalaprilat treatment.
Topics: Animals; Doxorubicin; Drug Interactions; Enalaprilat; Halothane; Heart Failure; Hemodynamics; Isoflu | 1991 |
Temporary mechanical circulatory support for severe cardiac failure: experimental study.
Topics: Animals; Counterpulsation; Dogs; Equipment Design; Halothane; Heart Failure; Heart-Assist Devices; H | 1991 |
[Various features of anesthesiologic provisions for surgery of pheochromocytoma].
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Aged; Anesthesia, General; Ether; Ethyl Ethers; Female; | 1986 |
Noncardiac surgery in the elderly patient with heart disease.
Topics: Aged; Anesthesia; Anesthesia, Inhalation; Arrhythmias, Cardiac; Cardiomyopathies; Coronary Artery By | 1985 |
[On the problem of preventive digitalization].
Topics: Anesthesia, Inhalation; Animals; Cardiovascular Diseases; Digitoxin; Guinea Pigs; Halothane; Heart F | 1965 |
Effect of halothane on altered contractility of isolated heart muscle obtained from cats with experimentally produced ventricular hypertrophy and failure.
Topics: Animals; Blood Pressure; Cardiomegaly; Cats; Electric Stimulation; Epinephrine; Halothane; Heart Fai | 1973 |
Surgical correction of the transposition complex in infancy.
Topics: Anesthesia, Inhalation; Child, Preschool; Edema; Extracorporeal Circulation; Female; Halothane; Hear | 1973 |
Effect of cyclopropane on contractile performance of cardiac muscle with experimental chronic heart failure.
Topics: Animals; Blood Pressure; Body Weight; Cardiac Output; Cats; Cyclopropanes; Electrocardiography; Fema | 1973 |
Hypoxia, hyperdynamic circulation, and the hazards of general anesthesia in patients with hepatic cirrhosis.
Topics: Anesthesia, General; Anesthesia, Inhalation; Cyclopropanes; Esophageal and Gastric Varices; Halothan | 1971 |
Verapamil in cardiac dysrhythmias during anaesthesia.
Topics: Adolescent; Adult; Aged; Anesthesia, Inhalation; Anti-Arrhythmia Agents; Arrhythmia, Sinus; Arrhythm | 1970 |
[Testing of the digitalis-like substances for protective and therapeutic effect against toxic stress of the cardiovascular system in situ].
Topics: Animals; Biological Assay; Cardiac Glycosides; Cardiovascular System; Digitoxin; Guinea Pigs; Haloth | 1967 |